Irinotecan plus temozolomide in relapsed Ewing sarcoma: an integrated analysis of retrospective studies

BACKGROUND: The prognosis of patients with relapsed Ewing sarcoma is poor. In this study, we aimed to pooled-analyze the efficacy and safety of the combination of irinotecan and temozolomide in treating patients with relapsed Ewing sarcoma. METHODS: PubMed, Cochrane CENTRAL, Web of Science, and EMBA...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bi-Cheng, Xiao, Bo-Ya, Lin, Guo-He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969362/
https://www.ncbi.nlm.nih.gov/pubmed/35361149
http://dx.doi.org/10.1186/s12885-022-09469-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969362/
https://www.ncbi.nlm.nih.gov/pubmed/35361149
http://dx.doi.org/10.1186/s12885-022-09469-5

Ejemplares similares